Cargando…
In Vitro Activity of Two Novel Antimicrobial Compounds on MDR-Resistant Clinical Isolates
The development of novel antibiotics is mandatory to curb the growing antibiotic resistance problem resulting in difficult-to-treat bacterial infections. Here, we have determined the spectrum of activity of cystobactamids and chelocardins, two novel and promising classes of molecules with different...
Autores principales: | Rima, Mariam, Pfennigwerth, Niels, Cremanns, Martina, Cirnski, Katarina, Oueslati, Saoussen, Gatermann, Sören G., d’Amélio, Nicola, Herrmann, Jennifer, Müller, Rolf, Naas, Thierry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451163/ https://www.ncbi.nlm.nih.gov/pubmed/37627685 http://dx.doi.org/10.3390/antibiotics12081265 |
Ejemplares similares
-
Increase in NDM-1 and NDM-1/OXA-48-producing Klebsiella pneumoniae in Germany associated with the war in Ukraine, 2022
por: Sandfort, Mirco, et al.
Publicado: (2022) -
Evaluation of the EasyScreen™ ESBL/CPO Detection Kit for the Detection of ß-Lactam Resistance Genes
por: Gonzalez, Camille, et al.
Publicado: (2022) -
Synthetic and Biological Studies on New Urea and Triazole Containing Cystobactamid Derivatives
por: Planke, Therese, et al.
Publicado: (2020) -
Validation of Three MicroScan(®) Antimicrobial Susceptibility Testing Plates Designed for Low-Resource Settings
por: Ronat, Jean-Baptiste, et al.
Publicado: (2022) -
Performance evaluation of the UMIC(®) Cefiderocol to determine MIC in Gram-negative bacteria
por: Dortet, Laurent, et al.
Publicado: (2023)